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Large numbers of individuals experience low back pain 
(LBP) during their lifetime [1,2]. LBP excruciates approxi-
mately 80% aging population and causes significant so-
cio-economic problem [3,4]. LBP often originates from the 
intervertebral disc degeneration (IVDD). The intervertebral 
disc (IVD) is a specialized biomechanical complex com-
posed of a hyper-hydrated and oligocellular central structure, 
namely, the nucleus pulposus (NP), and the annulus fibrous 
(AF) [5]. Most current available treatments for IVDD only 
work on symptomatic relief, and do not cure this disease. 
MSCs could be a cell therapy candidate in clinical IVD re-
generative therapies due to the avascular characteristic of 
NP [6]. MSCs are distributed in all tissues and recognized 
by their ability to self-renew, proliferate, and differentiate 
into several cell types. In the last few years, Blanco et al. [7] 
identified MSCs from the degenerate human NP and com-
pared them with bone marrow (BM) MSCs. They concluded 
that MSCs obtained from NP are quite similar to BM-MSCs, 
with the exception of their adipogenic differentiation ability. 
In this study, with the patients’ informed consent, seven 
disc samples were obtained from patients who underwent 
various spinal procedures (Table S1 in Supporting Infor-
mation). The age of the donors ranged from 10 to 37. The 
NP tissues were carefully separated from the AF using sur-
gical loupes without any visible contamination by the AF or 
any other tissue. NP tissue was mechanically fragmented 
and subjected to enzymatic digestion with collagenase II 
and trypsin. The digests were plated in a chemically defined 
medium, DMEM/F12. Cultures were passaged when they 
reached 80% confluence.  
In all cases, MSC-like cells from seven human NP tissue 
samples were expanded successfully. The cells cultured in 
plates presented polygonal-shape in the first generation, and 
mainly spindle-shape when passaged to the fifth generation 
(Figure 1A). MSC-like cells isolated from NP were spin-
dle-shape, which were similar to BM-MSCs derived from 
bone marrow.  
In order to further characterize the cells isolated from the 
NP tissues, the flow cytometric immunophenotyping was 
performed to all seven samples. Cell surface markers of the 
fifth generation cells were examined by flow cytometric 
analysis (Figure S1 in Supporting Information). Compared 
with the isotype control IgG1, about all cells were positive 
for CD44, CD29 and CD105 and negative for CD34, CD45, 
CD14 and HLA-DR, indicating that they are MSC-like cells. 
The result showed that MSC-like cells were isolated from 
human NP-tissues and expanded successfully.  
The cells presented similar growing behaviors (such as 
morphology) during passages and characteristics analyzed 
by flow cytometric immunophenotyping for all the seven 
NP samples. But the cell morphology of the passage 2 (po-
lygonal-shape) differs with that of the passage 5 (spin-
dle-shape) evidently. The cells at passage 2 and 5 from the 
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Figure 1  Characteristics of MSC-like cells from NP tissue and comparison of MSC-like cells between P2 and P5. A, MSC-like cells isolated from NP were 
expanded in vitro from passage 1 to 5. The BM-MSC (bone marrow MSC) is as control. The MSC-like cells were spindle-shape similar to that of BM-MSCs. 
B, Immunophenotypic histograms of P2 (red) and P5 (blue) cells, analyzed by FACS, were positive for CD44, CD29 and CD105 and negative for CD45, 
CD34, CD14 and HLA-DR. C, Multilineage differentiation of MSC-like cells. D, The mRNA quantification of the NP extracellular matrix markers in P2 and 
P5 cells were analyzed by real-time PCR. The results of each experiment are expressed relative to the quantity of -actin mRNA transcription as an internal 
control. 
patient No.1 were collected and further analyzed as repre-
sentation by real-time PCR and immunophenotyping com-
parison. Fluorescence intensity comparison between P2 and 
P5 MSC-like cells was performed by flow cytometric anal-
ysis. The fluorescence peaks of the makers CD44, CD29 
and CD105 of the passage 5, with higher intensity than that 
of P2, separated away from that of the passage 2; whereas 
the fluorescence peaks of the makers CD34, CD45, CD14 
and HLA-DR of the passage 5 and the passage 2 were near-
ly overlapped (Figure 1B). The results indicate that the 
concentration of MSC-like cells of the passage 5 is higher 
than that of the passage 2, suggesting that the MSC-like 
cells are truly expanded with the passage. In addition, the 
mRNA levels of NP extracellular matrix specific markers, 
including collagen type II, aggrecan, and SOX9, were quan-
tified by real-time quantitative PCR. The mRNA level of all 
three markers in P2 cells was dramatically higher than that 
in the P5 cells (P<0.05 for each) (Figure 1D). This assay 
suggests that the quantity of NP cells are larger in P2 than 
that in P5, and they do not get expanded with the passage 
due to the proliferation capability of the NP cell is weaker 
than that of MSC. Combination of the immunophenotyping 
analysis and real-time PCR results suggested that the 
MSC-like cell population of P5 was larger and more homo-
geneous than that of the P2, and indicated that the MSC-like 
cells were proliferated along with the generations. 
The expanded cells obtained from the six among the 
seven NP samples could differentiate into osteocytes, adi-
pocytes, and chondrocytes (Figure 1C), but only the NP 
samples from the patient No. 7 could not differentiate into 
adipocytes. This result is in accordance with the report by 
Blanco et al. that MSCs from IVD are able to differentiate 
into both osteocytes and chondrocytes, but cannot differen-
tiate into adipocytes in any of the cases [7]. The age of the 
patients in the case may account for the difference. MSC 
prefers to differentiate into osteogenesis cells, rather than 
adipogenesis cells along with the age [8]. The average age 
of the patient 16 is 18.5 years old, and the seventh patient 
is 37 years old, the only one who’s MSC-cells cannot be 
adipogenic differentiation. The average age in cases report-
ed by Blanco et al. is older than that in our cases, which 
could explain that there were no adipogenesis cells in their 
differentiation assays.  
In short, this report demonstrated that NP tissue contains 
MSC-like cells which could be isolated and proliferated in 
vitro. The spindle shape may be referred to as a morpholog-
ical characteristic of the MSC-like cells, although it needs 
more verification. The morphological, immunophenotypical 
and differentiation characteristics of the MSC cells prolifer-
ated met the criteria described according to the International 
Society for Cellular Therapy (ISCT) for MSC. Recent re-
search focused on tissue engineering and induced MSC en-
gineering for treating IVDD. Isolation of MSC-like cells 
from NP tissues and proliferation in vitro provide a platform 
for developing the therapies of IVDD with endogenous 
MSCs.  
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